Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid ...

In a bid to bolster pandemic preparedness, Sanofi has opened a modular vaccine manufacturing plant in Tuas Biomedical Park, Singapore.

French pharma major Sanofi has added a new plant in Singapore to make vaccines and other medicines, as the company seeks to ...

Sanofi has announced the opening of its new €558m-backed manufacturing facility in Singapore, which the company says ...

The French pharma firm is seeking to increase insulin production in Beijing as trade tensions between the EU and China simmer ...

SINGAPORE – A French pharmaceutical giant has opened a new $800 million manufacturing facility in Tuas Biomedical Park. The 58,000 sq m plant – Sanofi’s second factory in Singapore – will ...

Sanofi SA will invest around 1 billion euros ($1.1 billion) to build a new insulin production base in Beijing, its biggest ...

In 2024, domestic and foreign equity holders sold shares worth over $30 billion via block deals, showcasing sustained ...

Clinical trials for a revolutionary vaccine to treat acne will be conducted by the National Skin Centre in partnership with ...

Sanofi inaugurated its $800m healthcare manufacturing facility, Modulus, located in Tuas Biomedical Park to be operational in ...

The collaboration includes a phase 1 clinical study to start in the second quarter of 2025. The National Skin Centre Singapore, Sanofi, and the Agency for Science, Technology, and Research (A*STAR) ...